MFN2 and Alzheimer disease: In AD, layer 3 of the frontal cortex demonstrated further elevation of Drp-1 levels (p ≤ 0.0001) and reduction in Opa-1 levels (p = 0.0092), with no alterations in Mfn-2 levels compared to aging cases (Figure 2A–C).